Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00534014 · ClinicalTrials.gov registry record · NA
Vitamin C and Cardiovascular Risk
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00534014 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 8 participants.
The verdict
NCT00534014, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Study Goal #1: Determine the optimal oral dose of vitamin C to reduce surrogate markers of atherosclerosis (blockages in blood vessels) following the consumption of an atherogenic high fat lunch in type 2 diabetic individuals. Study Goal #2: After conducting the original study, we found that vitamin E was not effective in reducing the markers of oxidative stress, hypercoagulation, inflammation, and metabolic parameters in patients with type 2 diabetes. To date, data from randomized trials have largely demonstrated no significant benefit of vitamin E supplementation on the prevention of primary and/or secondary cardiovascular disease as once thought. Therefore, we decided to amend our current protocol to add a Part B to study only the effects of vitamin C at the following doses: 500 mg, 1000 mg, and 2000 mg daily (and include a placebo arm, as well.
Interventions
- DIETARY_SUPPLEMENT Vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00534014
The ClinicalTrials.gov registry entry for NCT00534014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin C is the first listed.
NCT00534014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00534014 about?
NCT00534014 is a clinical study titled "Vitamin C and Cardiovascular Risk". Study Goal #1: Determine the optimal oral dose of vitamin C to reduce surrogate markers of atherosclerosis (blockages in blood vessels) following the consumption of an atherogenic high fat lunch in type 2 diabetic individuals. Study Goal #2: After conducting the original study, we found that vitami...
What is the current status of trial NCT00534014?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2006-01. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00534014?
The interventions under investigation include: Vitamin C (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00534014?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.